3.61
Genenta Science Spa Adr Borsa (GNTA) Ultime notizie
Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa
Genenta secures €20M in mandatory convertible bond deal - Investing.com India
Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa
Genenta secures $21.9 million for cancer drug trial - Investing.com India
Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks
Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewswire Inc.
Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks
Genenta Science Updates ATM Sales Agreement with New Agent - TipRanks
Genenta Science SPA (ADR) trading resumes - TipRanks
Genenta Science SPA (ADR) trading halted, volatility trading pause - TipRanks
3 US Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance
Genenta Science CEO to present at U.S. Senate meeting - TipRanks
Genenta Science receives Buy rating amid trial approval - Investing.com
Genenta Science Announces Shareholder Meeting - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
DHR Stock Quote Price and Forecast - CNN
Danaher (DHR) Stock Price, News & Analysis - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):